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1999), yet KARs make no detectable ionotropic contribu-
tion to synaptic responses in these cells. In the mean-
time, a metabotropic function has been reported for
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University of Southampton the presynaptic KARs on CA1 interneurons (Rodrı´guez-
Moreno and Lerma, 1998). To resolve the enigma of aBassett Crescent East
Southampton SO16 7PX functional receptor without any apparent function, we
tested the hypothesis that KARs have a metabotropic2Wolfson Institute for Biomedical Research
University College London action in CA1 pyramidal cells.
A candidate target for any metabotropic action is theGower Street
London WC1E 6BT slow afterhyperpolarization (sAHP), which follows short
bursts of action potentials and is generated by a voltage-United Kingdom
independent, Ca2-dependent K current (Lancaster
and Adams, 1986). The sAHP (or current, IsAHP) lasts up
to several seconds and is activated proportionally toSummary
the number and frequency of action potentials within a
burst. It thus acts as a negative feedback mechanismKainate receptors (KARs) on CA1 pyramidal cells make
that limits repetitive spiking (Madison and Nicoll, 1984)no detectable contribution to EPSCs. We report that
and burst firing (Traub et al., 1993) during hyperexcitabil-these receptors have a metabotropic function, as
ity. A spectrum of neurotransmitters like noradrenaline,shown previously for CA1 interneurons. Brief kainate
acetylcholine, or glutamate, via G protein-coupled re-exposure caused long-lasting inhibition of a postspike
ceptors, will inhibit sAHP (Nicoll, 1988). The transductionpotassium current (IsAHP) in CA1 pyramidal cells. The mechanism for noradrenaline action involves the cAMP/pharmacological profile was independent of AMPA re-
protein kinase A pathway (Madison and Nicoll, 1986;ceptors or the GluR5 subunit, indicating a possible
Pedarzani and Storm, 1993), whereas acetylcholine hasrole for the GluR6 subunit. KAR inhibition of IsAHP did been suggested to act through Ca2-calmodulin-depen-not require ionotropic action or network activity, but
dent protein kinase II (Mu¨ller et al., 1992). Protein kinasewas blocked by the inhibitor of pertussis toxin-sensi-
C (PKC) activation also has been shown to inhibit thetive G proteins, N-ethylmaleimide (NEM), or the PKC
sAHP (Malenka et al., 1986), but the transmitter linkedinhibitor calphostin C. These data suggest how KARs,
to this action remains to be identified.putatively containing GluR6, directly increase excit-
Although kainate is known to promote network oscilla-ability of CA1 pyramidal cells and help explain the
tions (Buhl et al., 1998) as well as seizure-like activity,propensity for seizure activity following KAR acti-
an understanding of kainate action against intrinsic py-vation.
ramidal cell conductances (Robinson and Deadwyler,
1981; Ashwood et al., 1986; Gho et al., 1986) has not kept
Introduction pace with advances in the field of glutamate receptor
pharmacology. We show here that GluR6-containing
Kainate is an excitotoxic glutamate analog that has well- kainate receptors in CA1 pyramidal neurons are the
known actions to increase excitability and produce sei- likely trigger for PKC-mediated inhibition of sAHP.
zure-like activity in the hippocampus (Westbrook and
Lothman, 1983, Fisher and Alger, 1984; Ben-Ari and Cos-
sart, 2000). Although these actions of kainate have been Results
studied for many years, our understanding of the kainate
receptor (KAR) itself has lagged behind that of other The Slow AHP in Pyramidal Cells Is Inhibited
ionotropic glutamate receptors. It is now apparent that, by High-Affinity Kainate Receptors
in many early studies, kainate was used in ways that The first series of experiments tested whether kainate
did not discriminate between actions on AMPA recep- inhibition of IsAHP was mediated by a direct postsynaptic
tors and KARs. However, recent evidence has revealed action of a kainate-preferring glutamate receptor. Bath
how KAR modulation of synaptic mechanisms may con- application of 200 nM kainate for 5–15 min caused a
tribute to hippocampal hyperexcitability (reviewed in long-lasting inhibition of the peak amplitude of IsAHP
Frerking and Nicoll, 2000). (34%  6%, mean  SEM, n  7; Figures 1A and 2A).
Kainate receptors have been shown to mediate excit- This action reached a plateau regardless of prolonged
atory postsynaptic potentials or currents in CA1 in- kainate application (15 min, Figure 1A), and lasted for
terneurons (Cossart et al., 1998; Frerking et al., 1998) more than 1 hr after kainate application (data not shown).
and CA3 pyramidal neurons (Vignes and Collingridge, IsAHP inhibition was not accompanied by significant
1997; Castillo et al., 1997). In CA1 pyramidal neurons, changes in holding current.
knockout studies have demonstrated that GluR6-con- To test if IsAHP inhibition was an indirect effect, caused
taining KARs produce inward currents (Bureau et al., by action potential-dependent transmitter release, fur-
ther experiments were conducted in the presence of 1
M tetrodotoxin (TTX) and 5 mM tetraethylammonium3 Correspondence: h.v.wheal@soton.ac.uk
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Figure 1. Kainate Inhibits IsAHP by a Direct Action on CA1 Pyramidal Cells
(A) 200 nM kainate application reduced the amplitude of IsAHP. The peak amplitudes of IsAHP (circles) and the holding current values (triangles)
are plotted against time. Sample traces were obtained before and after kainate application in the same neuron (averages of 15 trials).
(B) The inhibition of IsAHP by kainate was reproduced in the presence of 1 M TTX and 5 mM TEA.
(C) Comparison of the 200 nM kainate evoked inhibition with and without 1 M TTX plus 5 mM TEA. The data presented are the average
percentage inhibition of IsAHP (mean  SEM).
(D) Summary time course of IsAHP inhibition from five experiments (mean  SEM) recorded in the presence of the cocktail of antagonists: DL-
AP5 (100 M), GYKI52466 (100 M), MCPG (1 mM), MSOP (250 M), picrotoxin (100 M), 2-OH-saclofen (200 M), atropine sulfate (1 M),
DPCPX (0.1 M), AM 251 (2 M), and naloxone (10 M).
(TEA) (Figure 1B). TEA was added in these experiments prior application of CNQX (20 M, n  6; Figures 2B
and 3). In contrast, application of 20 M CNQX afterin order to facilitate calcium spikes so that IsAHP could be
evoked reliably. The kainate inhibition of IsAHP observed in kainate did not relieve IsAHP inhibition (n  3; Figure 2C).
Therefore, the prolonged action is unlikely to be due tothe presence of TTX was indistinguishable from controls
(35%  3% in eight cells; Figure 1C). persistent receptor activation or slow washout of the
kainate but may, instead, reflect the action of an intracel-It has been shown that kainate can increase spontane-
ous GABA release from CA1 interneurons (Cossart et al., lular messenger. The effect of kainate on IsAHP was con-
centration dependent, reaching a plateau of 34% at 1001998). In order to test whether the effect of kainate on
IsAHP depended on any secondary activation of receptors nM with an IC50  15 nM (Figure 2D). A more complete
block was observed with high concentrations of kainateother than the kainate subtype, we used a cocktail of
antagonists. Blockers were used for the NMDAR (100 M (84% at 10M), which were associated with large inward
currents. We have restricted our analysis to concentra-DL-AP5), AMPAR (100 M GYKI52466), mGluR (1 mM
MCPG and 250 M MSOP), GABAAR (100 M picrotoxin), tions that were not associated with clear ionotropic ef-
fects.GABABR (200 M 2-OH-saclofen), muscarinic AchR (1
M atropine sulfate), opioid (10 M naloxone), canna- In order to identify the receptor subtype responsible
for kainate-induced inhibition of IsAHP, we tested the ef-binoid CB1 (2 M AM 251), and adenosine receptors (0.1
M DPCPX). Under these conditions, a 5 min kainate fects of different AMPA and kainate receptor agonists
and antagonists. Figure 3 shows a summary histogramapplication inhibited the peak amplitude of IsAHP (32% 
5%, n  5; Figure 1D) with a time course similar to that for these effects. Domoate (200 nM), which is a more
potent agonist of kainate receptors than kainate itselfrecorded in control experiments (n  7; Figure 2A).
The effect of kainate showed a requirement for AMPA/ (Debonnel et al., 1989), also caused substantial inhibi-
tion of IsAHP (51% 6% versus 34% 6%, respectively).kainate receptors, since it was completely abolished by
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Figure 2. IsAHP Inhibition Is Mediated by AMPA/KA Receptor Activation
(A) Summary time course of IsAHP inhibition from seven experiments (mean  SEM). The traces illustrate data from one neuron before and after
200 nM kainate application.
(B) Prior application of 20 M CNQX blocked the effect of kainate. Summary time course of IsAHP inhibition (n  6). The traces (averages of 15
trials) were recorded in the presence of 20 M CNQX before and after 200 nM kainate was added to the solution.
(C) 20 M CNQX applied after 200 nM kainate did not relieve IsAHP inhibition. Summary time course of IsAHP inhibition (n  3).
(D) Dose-response curve for kainate-induced inhibition of IsAHP. Each symbol represents average of at least four cells. The data were fitted
with a logistic curve which gives an IC50  15 nM.
IsAHP was not affected by the potent AMPA receptor ago- function of kainate receptors acting through pertussis
toxin-sensitive G proteins and protein kinase C was de-nist (S)-5-fluorowillardiine (300 nM, n  7) (Wong et al.,
scribed for presynaptic kainate receptors on CA1 in-1994; Jane et al., 1997). The nonselective AMPA/kainate
terneurons (Rodrı´guez-Moreno and Lerma, 1998). Wereceptor antagonist CNQX (20 M) blocked the effect
tested for metabotropic actions using an inhibitor ofof kainate. Kainate activation of AMPA receptors was
pertussis toxin-sensitive G proteins, N-ethylmaleimidethen tested with the blocker GYKI52466 (100M) (Pater-
(NEM) (Heuss et al., 1999; Frerking et al., 2001), and thenain et al., 1995), which was ineffective at five to ten
protein kinase C inhibitor, calphostin C. Prior applicationtimes the reported IC50 (Bleakman et al., 1996). Kainate
of NEM (50M) prevented the inhibitory action of kainatereceptors found in CA1 interneurons have been reported
(200 nM) on IsAHP in seven experiments (Figure 4). NEMto contain GluR5 subunits (Cossart et al., 1998). There-
caused some reduction of IsAHP amplitude, possibly duefore, we used the GluR5 subtype-preferring agonist
to calcium current rundown, which has been reportedATPA (Clarke et al., 1997) to test for the involvement of
with this reagent (Shapiro et al., 1994; Viana and Hille,this subunit. At concentrations known to be effective
1996; Delmas and Gola, 1997). Preincubation of theagainst GluR5 subunits (Clarke et al., 1997), ATPA (2 M)
slices with 1 M calphostin C for 2–4 hr prevented IsAHPdid not produce any changes in IsAHP amplitude (n  5,
inhibition by kainate (200 nM, n  10, Figure 4). In fourFigure 3). These data are consistent with a direct action
of these cells, subsequent application of 10 M nor-of kainate on CA1 pyramidal cells, acting via GluR6-
adrenaline blocked IsAHP. This demonstrates that the cal-containing kainate receptors to modulate IsAHP.
phostin C treatment was not causing a broad spectrum
kinase inhibition because it did not block sensitivity to
Kainate Action in Pyramidal Cells Involves noradrenaline, which is known to reduce IsAHP via PKA
Metabotropic Function (Pedarzani and Storm, 1993). Therefore, these data sug-
The inhibition of IsAHP was not associated with clear iono- gest that kainate inhibition of IsAHP has a specific require-
ment for PKC.tropic effects of the kainate receptor. A metabotropic
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Figure 3. Summary Histogram of the Effects
of AMPA and Kainate Receptor Agonists and
Antagonists on IsAHP
The traces show the effect of 200 nM do-
moate on IsAHP. Each trace represents the av-
erage of 15 trials recorded before and after
domoate application. The bars are the aver-
age percentage inhibition of IsAHP (mean 
SEM). Kainate (200 nM) and domoate (200
nM) both produce inhibition of IsAHP. The ac-
tion of kainate can be blocked by CNQX (20
M), but not by GYKI52466 (100 M). (S)-5-
fluorowillardiine (300 nM) and ATPA (2 M)
were ineffective.
Kainate Acts Downstream of Ca2 Influx (50–80 ms 0.1–1.0 nA) generated a calcium action poten-
tial. The addition of kainate at concentrations that inhibitto Enhance Excitability
Kainate has been reported to inhibit voltage-dependent IsAHP (200 nM, Figure 5A) did not affect either the width
or the amplitude of calcium spikes; this was quantifiedCa2 currents (Nistri and Cherubini, 1991) and the inhibi-
tion of IsAHP might, in principle, be a simple consequence by measuring the area under the calcium spikes. Figure
5B shows the time course of the calcium spike area forof this action. This was tested in two ways, first by
examining the effect of kainate on Ca2 action poten- the data in Figure 5A; the average data (inset, Figure
5B) from eight experiments shows that there was notials. In current-clamp experiments in the presence of
1 M TTX and 5 mM TEA, depolarizing current injection change in calcium spike area (5%  3%) 10 min after
Figure 4. Kainate-Induced Inhibition of IsAHP
Involves Metabotropic Function
Sample traces (averages of 15 trials) were
recorded in calphostin C-treated slices be-
fore and after kainate application, and after
subsequent application of noradrenaline. The
histogram shows the average percentage in-
hibition of IsAHP (mean SEM). 200 nM kainate
inhibited IsAHP in control slices (white bar).
Prior bath application of NEM (50 M)
blocked the effect of kainate (hatched bar)
(p  0.0006, unpaired t test). In calphostin
C (1 M) treated slices (black bars) kainate-
induced inhibition was significantly reduced
(p 0.002), subsequent application of 10 M
noradrenaline blocked IsAHP.
Metabotropic Function of KARs in Pyramidal Neurons
111
Stocker et al., 1999) and is distinct from the current
underlying the sAHP. In these experiments, the mAHP
was studied in isolation following block of IsAHP by inclu-
sion of 100 M 8Br-cAMP in the electrode. The mAHP
current was subject to a gentle rundown; however, this
was unaffected by a 10 min application of 200 nM kai-
nate (n  5, Figure 5C). This evidence suggests that
inhibition of voltage-dependent Ca2 channels is not
responsible for the kainate-induced reduction of IsAHP.
Finally, we resolved the consequences of kainate ac-
tion on excitability by studying the increase in action
potential firing caused by 200 nM kainate. Spike fre-
quency is the product of a number of factors including
persistent Na current and M current in addition to IsAHP,
so the slight drift after kainate application may result
from altered balance between other ionic currents.
Nonetheless, 200 nM kainate, which reliably causes a
30%–40% reduction of IsAHP (previous figures), resulted
in increased spiking in response to 800 ms depolarizing
current steps (Figure 6A). The membrane potential was
maintained constant for the duration of the experiment.
The summary data time course (Figure 6B) shows that
spike number was stable during the 10 min control pe-
riod and then increased significantly from 5.4  0.4
spikes before kainate to 8.3  0.8 spikes 10 min after
kainate addition (p  0.006), an average 53% increase
in this measure of excitability.
Discussion
Our first concern in this study was to test whether the
actions of kainate on the sAHP were indirect. There is
particularly strong expression of mRNA for KAR sub-
units in the CA3 pyramidal layer (Bureau et al., 1999).
This raises the question: does bath-applied kainate act
indirectly by driving CA3 pyramidal cells? Several lines
of evidence exclude this interpretation. The relation of
IsAHP inhibition to kainate concentration had an IC50 of 15
nM and plateau at 100 nM. These concentrations are
not associated with inward currents in CA1 pyramidal
cells (this paper; Robinson and Deadwyler, 1981; Cas-
tillo et al., 1997; Schmitz et al., 2000) but are comparable
to the reported binding affinities (reviewed in Lerma etFigure 5. Kainate Does Not Affect Ca2 Influx
al., 2001). Inhibition of IsAHP by kainate was identical in(A) 200 nM kainate application reduced IsAHP (bottom traces) without
the presence of either TTX or a cocktail of receptorchanging the profiles of calcium action potentials (top traces), which
antagonists; this excludes any role for action potential-were generated in response to 50 ms depolarizing voltage steps.
All traces were obtained in the presence of 1 M TTX and 5 mM dependent release or secondary activation of other re-
TEA. ceptor types. These results are strong evidence that IsAHP
(B) Normalized time course of calcium spike areas for the data can be inhibited by direct activation of kainate receptors
illustrated above. The inset shows average histogram for eight ex-
on CA1 pyramidal neurons, leading to increased excit-periments (mean  SEM) where the effects of 200 nM kainate on
ability of these cells.IsAHP and Ca2 spikes are compared.
Ionotropic responses mediated by KARs in CA1 pyra-(C) Summary time course for the peak amplitude of the medium
duration (apamin-sensitive) AHP current, which shows no sensitivity midal cells are absent in GluR6-deficient mice (Bureau
to kainate. Inset, three traces show control, kainite, and apamin et al., 1999). In concert with these observations, our
sensitivity of mAHP tail currents following a depolarization. experiments excluded any role for AMPAR or GluR5
subunits in kainate inhibition of IsAHP. However, the char-
acteristics of the putative GluR6 response reported herekainate application although the sAHP showed a reduc-
tion of 38%  6% at this time. If kainate action on IsAHP indicated a requirement for a second messenger. Sensi-
tivity to the reagent NEM suggests the involvement ofwas secondary to a reduction of Ca2 influx, it should
also inhibit other Ca2-dependent K currents. This hy- a pertussis toxin-sensitive G protein, although the nature
of the coupling between KARs and G proteins is unclear.pothesis was tested on the medium duration AHP
(mAHP) in CA1 pyramidal cells, which is generated by Calphostin C blocked the action of kainate without af-
fecting the ability of noradrenaline to inhibit IsAHP. Thisapamin-sensitive SK channels (Ko¨hler et al., 1996;
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Kainate has been reported to decrease the Ca2 cur-
rent in hippocampal neurons (Nistri and Cherubini,
1991), which might explain the reduction of a Ca2-
dependent event like the sAHP. We found that inhibition
of the sAHP was not associated with alteration in Ca2
spikes (observed also for PKC activation) (Malenka et
al., 1986), nor was there any action of kainate on the
apamin-sensitive SK current present in these cells which
also requires Ca2 entry (Stocker et al., 1999). These two
independent findings demonstrate that the reduction of
IsAHP was not secondary to reduced Ca2 influx. This
observation is comparable to sAHP inhibition evoked
by other neurotransmitters, like noradrenaline (Madison
and Nicoll, 1986; Gray and Johnston, 1987, Lancaster
and Batchelor, 2000), and acetylcholine (Cole and Nicoll,
1984; Kno¨pfel et al., 1990), which also appear to inhibit
the sAHP independently of Ca2 influx.
Kainate receptors which mediate presynaptic actions
can be activated by synaptically evoked glutamate re-
lease (Min et al., 1999; Schmitz et al., 2000). On CA1
pyramidal cells, however, there is no KAR ionotropic
component to synaptic responses (Frerking and Nicoll,
2000), and it remains an open question whether the
metabotropic action of KAR described here can be re-
cruited by synaptic activation. Alternatively, it is con-
ceivable that activation might result only from the exces-
sive glutamate release that occurs during ischaemia or
seizures. While low levels of agonist activate a number
of KARs, it is the metabotropic nature of this change in
intrinsic membrane properties that would help maintain
increased pyramidal cell excitability through any tran-
sient increase of interneurone activity or GABA-release
(Cossart et al., 1998; Semyanov and Kullmann, 2001).
Higher levels of glutamate could set up a positive feed-
back system in which GABA-mediated inhibition is de-
creased (Fisher and Alger, 1984; Clarke et al., 1997;
Figure 6. Kainate Increases Intrinsic Excitability of CA1 Pyramidal Rodrı´guez-Moreno et al., 1997; Min et al., 1999), leading
Cells
to burst activity which is exacerbated by the reduction
(A) Sample traces evoked by 800 ms depolarizing pulse were ob-
in the sAHP which normally follows the burst. Furthertained in one neuron before and after kainate application. The sum-
glutamate release could additionally activate metabo-mary time course shows the change in average spike number
tropic glutamate receptors, which have also been re-(mean  SEM) caused by bath application of 200 nM kainate.
(B) Histogram shows averaged data for nine experiments (mean  ported to block sAHP (Charpak et al., 1990; Abdul-Ghani
SEM), indicating that there is a significant increase in excitability et al., 1996). These indirect actions may contribute to
(p  0.005). the more complete block of IsAHP observed with high
(3–10 M) kainate concentrations which depolarize neu-
rons. The end result of these KAR-dependent conver-indicates a requirement for PKC in a transduction mech-
gent mechanisms may be the long-term loss of the sAHPanism, which is distinct from the PKA-mediated action
and chronic hyperexcitability observed in the hippocam-of noradrenaline (Pedarzani and Storm, 1993). Such a
pus following kainate lesions (Ashwood et al., 1986).role for PKC is similar to the previously reported metabo-
tropic function of KARs involved in presynaptic modula-
tion of GABA release (Rodrı´guez-Moreno and Lerma, Experimental Procedures
1998). Since independent PKC activation also blocks
Hippocampi were obtained from 14- to 19-day-old rats after decapi-the sAHP (Malenka et al., 1986), we suggest that PKC
tation. Transverse slices (400 m) were cut using a Vibratome andis not just a constitutive requirement, but that KARs
incubated in an interface chamber at room temperature before trans-
activate a PKC-based signaling pathway. When inhibi- fer to a submerged recording chamber. The storage and perfusion
tion of the sAHP by PKC was first reported (Malenka et solution contained 119 mM NaCl, 2.5 mM KCl, 1.3 mM MgSO4, 2.5
mM CaCl2, 1 mM NaH2PO4, 26 mM NaHCO3, and 11 mM glucoseal., 1986), the common supposition was that muscarinic
and was gassed with 95% O2/5% CO2. Recordings were made atreceptors might be the trigger for this action. This possi-
28C–30C with recording pipettes containing 150 mM potassiumbility has been comprehensively invalidated (Mu¨ller et
methylsulphate, 10 mM KCl, 10 mM Hepes, 4 mM NaCl, 4 mMal., 1992; Pedarzani and Storm, 1996; Engisch et al.,
Mg2ATP, and 0.4 mM Na4GTP. Osmolarity was adjusted to 280–2901996), and the data presented here fills this gap by sug- mosmol l1 and pH to 7.35–7.4 with KOH. The methylsulphate anion
gesting that KARs are coupled to inhibition of the sAHP was used because it has been shown to preserve IsAHP in a form
similar to that observed with sharp electrode recordings (Lancasterby PKC.
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and Adams, 1986; Zhang et al., 1994). Chemicals were purchased Debonnel, G., Beauchesne, L., and de Montigny, C. (1989). Domoic
acid, the alleged “mussel toxin,” might produce its neurotoxic effectfrom Sigma (Poole, UK), with the following exceptions: kainic acid
(Ocean Products International, Shelburne, Nova Scotia, Canada; through kainate receptor activation: an electrophysiological study
in the dorsal hippocampus. Can. J. Physiol. Pharmacol. 67, 29–33.or Sigma), NaCl (Fisher Chemicals, Loughborough, UK), potassium
methylsulphate (ICN Biomedicals, Aurora, OH), Calphostin C (Cal- Delmas, P., and Gola, M. (1997). Exotoxin-insensitive G proteins
biochem, Nottingham, UK), CNQX, domoic acid, ATPA, (S)-5-fluoro- mediate synaptically evoked muscarinic sodium current in rabbit
willardiine, DL-AP5, (S)-MCPG, MSOP, 2-OH-saclofen, DPCPX, sympathetic neurons. J. Physiol. 498, 627–640.
AM 251, naloxone, and tetrodotoxin were obtained from Tocris Cook-
Engisch, K.L., Wagner, J.J., and Alger, B.E. (1996). Whole-cell volt-son (Bristol, UK).
age-clamp investigation of the role of PKC in muscarinic inhibitionWhole-cell patch-clamp recordings were made from stratum pyra-
of IAHP in rat CA1 hippocampal neurons. Hippocampus 6, 183–191.midale without visual identification. Open pipette resistance was
Fisher, R.S., and Alger, B.E. (1984). Electrophysiological mecha-2–4 M, and access resistance during recordings was20 M. IsAHP
nisms of kainic acid-induced epileptiform activity in the rat hippo-was recorded (Axopatch 200B or 1D amplifier, Axon Instruments) in
campal slice. J. Neurosci. 4, 1312–1323.neurons voltage clamped at holding potentials from50 to65 mV
following 80 ms voltage steps to 10 mV applied every 20 s. The Frerking, M., and Nicoll, R.A. (2000). Synaptic kainate receptors.
records were filtered at 1 kHz and sampled at 2 kHz. Current-clamp Curr. Opin. Neurobiol. 10, 342–351.
recordings were made at membrane potentials from 50 to 65 Frerking, M., Malenka, R.C., and Nicoll, R.A. (1998). Synaptic activa-
mV (AxoClamp 2B, Axon Instruments). Long (800 ms) and brief tion of kainate receptors on hippocampal interneurons. Nat. Neu-
(50–80 ms) depolarizing current steps (0.03–1.0 nA) were used to rosci. 1, 479–486.
evoke action potentials and slow afterhyperpolarizations. Data are
Frerking, M., Schmitz, D., Zhou, Q., Johansen, J., and Nicoll, R.A.given as means  SEM, and the significance was assessed with
(2001). Kainate receptors depress excitatory synaptic transmissionStudent’s t test.
at CA3-CA1 synapses in the hippocampus via a direct presynaptic
action. J. Neurosci. 21, 2958–2966.Acknowledgments
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